|By Business Wire||
|June 17, 2014 12:19 PM EDT||
Assurex Health, the leading personalized medicine company helping physicians select the right medication for patients with mental health disorders and chronic pain, named James S. Burns Executive Chairman and Virginia (Gina) C. Drosos as President and Chief Executive Officer, effective July 1, 2014.
Assurex Health Leadership Team (from left to right): James Burns, Executive Chairman; Virginia (Gina) Drosos, President and Chief Executive Officer; and Donald Wright, Chief Operating Officer. (Photo: Business Wire)
Burns, who has served as CEO since 2009, will chair the Board of Directors, as well as focusing on long-term development of Assurex Health’s proprietary technology platform and overseeing the company’s Scientific Advisory Board. Drosos, who joined the company in August 2013, adds the CEO role to her responsibilities as President and leader of the commercial organization and fast growing program to drive broad awareness and adoption of GeneSight.
Company Chief Operating Officer, Donald R. Wright, who has led Assurex operations since 2008, will continue to lead major Assurex Health initiatives related to informatics innovation, product development, laboratory operations, reimbursement, human resources and government affairs.
“Assurex Health has been built on industry-leading genetic technology, informatics, intellectual property, and clinical data,” said Burns. “We address a very large market for our GeneSight products with a demonstrated clinical and economic benefit. Our goal now is to scale the company commercially and make GeneSight technology broadly available to clinicians and their patients. Gina has the proven leadership qualities and ability to scale the company and lead a substantial expansion of our patient and clinician customer base. Gina, Don, and I will continue working closely together to help make GeneSight-enabled mental wellness a reality.”
Fast Growth Signals Increasing Acceptance of Flagship GeneSight Test
The new management roles allow Assurex Health to enhance its focus on leading-edge science, clinical data and driving awareness and adoption as it continues its rapid growth, helping thousands of clinicians select the right medications for nearly 100,000 patients with neuropsychiatric disorders. In the past year, Assurex Health has almost doubled its workforce to more than 200 employees, and doubled the number of patients it tests each month.
Assurex Health’s GeneSight technology helps guide clinicians making medication decisions for patients with neuropsychiatric disorders such as depression, PTSD, ADHD, bipolar disorder, or chronic pain. Compared with the current standard of care, patients whose treatment was guided by GeneSight had double the odds of remission and response to medication, and experienced 70 percent greater improvement in depressive symptoms.
“Under Jim’s leadership, we are seeing tremendous growth and success, and I am honored to succeed him as CEO,” Drosos said. “My vision for Assurex Health is to make GeneSight a standard of care. We remain dedicated to helping clinicians better their treatment of patients with mental health disorders, changing how neuropsychiatric medicines are prescribed, and helping speed patients on the road to recovery.”
“With Gina in her new role, I am excited to see where we can take this company,” said Wright. “We have come a long way in developing informatics-based products that are clinically relevant and easy to use. Now, we’re helping more clinicians and patients across the country than ever before realize there is a better, more effective way to make and manage medication decisions.”
Enhanced Coverage, Strong Support
Assurex Health continues to rapidly increase the number of health plans that reimburse the cost of GeneSight testing. This includes government payers, as well as growing relationships with commercial payer organizations. Last month, Assurex Health announced that it had become an in-network provider with The Alliance, a not-for-profit cooperative serving employers who self-fund their health benefits in Wisconsin, Illinois and Iowa. Today, Assurex Health announced that it has joined the SIHO Insurance Services Provider Network, an innovative cooperative of local physicians, hospitals and employers in the Midwest.
GeneSight is a laboratory-developed pharmacogenomic test that uses cutting edge technology to measure and analyze clinically important genomic variants in the treatment of psychiatric disorders. The results of the GeneSight report can help a clinician understand the way a patient’s unique genomic makeup may affect certain psychiatric medications. The analysis is based on pharmacogenomics, the study of genomic factors that influence an individual’s response to drug treatments, manufacturers’ FDA approved drug labels, peer reviewed scientific and clinical publications, and proven drug pharmacology.
Assurex Health has four laboratory developed tests powered by GeneSight technology. The GeneSight Psychotropic test analyzes how a patient’s genes may affect his/her metabolism and response to FDA-approved medicines commonly prescribed to treat depression, anxiety, bipolar disease, schizophrenia or other behavioral health conditions. GeneSight Analgesic gives physicians a powerful genetic-based tool to help evaluate medication responses for patients with acute or chronic pain across four drug classes: opioids, NSAIDs, muscle relaxants and opioid dependency medications. GeneSight ADHD provides information about patient response to ADHD medications, including stimulant and non-stimulant medications. GeneSight MTHFR helps determine if additional folic acid supplementation is necessary. More than 8,000 healthcare practitioners have used GeneSight to guide treatment decisions for over 90,000 patients.
About Assurex Health
Assurex Health is a personalized medicine company that specializes in pharmacogenomics and is dedicated to helping physicians determine the right medication for individual patients with neuropsychiatric and other medical conditions. The company was founded to commercialize industry-leading personalized medicine technology for neuropsychiatric conditions. Assurex Health has licensed patented technology from Mayo Clinic and Cincinnati Children’s Hospital Medical Center.
Assurex recently disclosed a $32 million financing round from GE Capital, Silicon Valley Bank and additional investments by Sequoia Capital, Claremont Creek Ventures, CincyTech, Allos Ventures, and others. The company also launched its first product-specific website for GeneSight earlier this month. Learn more at www.assurexhealth.com and www.genesight.com. Assurex Health is a DBA of AssureRx Health, Inc.
Wearable technology was dominant at this year’s International Consumer Electronics Show (CES) , and MWC was no exception to this trend. New versions of favorites, such as the Samsung Gear (three new products were released: the Gear 2, the Gear 2 Neo and the Gear Fit), shared the limelight with new wearables like Pebble Time Steel (the new premium version of the company’s previously released smartwatch) and the LG Watch Urbane. The most dramatic difference at MWC was an emphasis on presenting we...
Mar. 29, 2015 04:00 PM EDT Reads: 1,390
Businesses are looking to empower employees and departments to do more, go faster, and streamline their processes. For all workers – but mobile workers especially – utilizing the cloud to reconnect documents and improve processes without destructing existing workflows can have a dramatic impact on productivity. In his session at 16th Cloud Expo, Mark Grilli, vice president of Acrobat Solutions marketing at Adobe Systems Incorporated, will outline new ways that the cloud is changing the way peo...
Mar. 29, 2015 04:00 PM EDT Reads: 1,310
SYS-CON Events announced today that Vitria Technology, Inc. will exhibit at SYS-CON’s @ThingsExpo, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Vitria will showcase the company’s new IoT Analytics Platform through live demonstrations at booth #330. Vitria’s IoT Analytics Platform, fully integrated and powered by an operational intelligence engine, enables customers to rapidly build and operationalize advanced analytics to deliver timely business outcomes ...
Mar. 29, 2015 03:30 PM EDT Reads: 2,159
Are your applications getting in the way of your business strategy? It’s time to rethink your IT approach. In his session at 16th Cloud Expo, Madhukar Kumar, Vice President, Product Management at Liaison Technologies, will discuss a new data-centric approach to IT that allows your data, not applications, to inform business strategy. By moving away from an application-centric IT model where data integration and analysis are subservient to the constraints of applications, your organization will b...
Mar. 29, 2015 03:15 PM EDT Reads: 2,541
WSM International has launched a DevOps services division that offers assessment, consulting and implementation to large enterprises and organizations with complex infrastructures. The concept of DevOps is to blend information technology (IT) software development with operations to optimize the computing infrastructure according to the specific needs of the organization. According to a recent press release from Gartner, "By 2016, DevOps will evolve from a niche strategy employed by large cloud ...
Mar. 29, 2015 03:00 PM EDT Reads: 1,258
SYS-CON Events announced today that Solgenia will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY, and the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Solgenia is the global market leader in Cloud Collaboration and Cloud Infrastructure software solutions. Designed to “Bridge the Gap” between Personal and Professional S...
Mar. 29, 2015 03:00 PM EDT Reads: 2,813
SYS-CON Events announced today that QTS Realty Trust, one of the nation’s largest and fastest-growing providers of data center facilities and cloud services and a leader in security and compliance, will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. QTS Realty Trust, Inc. (NYSE: QTS) is a leading national provider of data center solutions and fully managed services, and a leader in security and compliance...
Mar. 29, 2015 03:00 PM EDT Reads: 1,239
SYS-CON Events announced today that WSM International (WSM), the world’s leading cloud and server migration services provider, will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. WSM is a solutions integrator with a core focus on cloud and server migration, transformation and DevOps services.
Mar. 29, 2015 03:00 PM EDT Reads: 1,242
SYS-CON Events announced today that Liaison Technologies, a leading provider of data management and integration cloud services and solutions, has been named "Silver Sponsor" of SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York, NY. Liaison Technologies is a recognized market leader in providing cloud-enabled data integration and data management solutions to break down complex information barriers, enabling enterprises to make sm...
Mar. 29, 2015 03:00 PM EDT Reads: 3,436
SYS-CON Events announced today that MangoApps will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY., and the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. MangoApps provides private all-in-one social intranets allowing workers to securely collaborate from anywhere in the world and from any device. Social, mobile, and eas...
Mar. 29, 2015 03:00 PM EDT Reads: 3,016
Sematext is a globally distributed organization that builds innovative Cloud and On Premises solutions for performance monitoring, alerting and anomaly detection (SPM), log management and analytics (Logsene), and search analytics (SSA). We also provide Search and Big Data consulting services and offer 24/7 production support for Solr and Elasticsearch.
Mar. 29, 2015 02:15 PM EDT Reads: 1,486
The WebRTC Summit 2014 New York, to be held June 9-11, 2015, at the Javits Center in New York, NY, announces that its Call for Papers is open. Topics include all aspects of improving IT delivery by eliminating waste through automated business models leveraging cloud technologies. WebRTC Summit is co-located with 16th International Cloud Expo, @ThingsExpo, Big Data Expo, and DevOps Summit.
Mar. 29, 2015 02:00 PM EDT Reads: 1,569
The speed of software changes in growing and large scale rapid-paced DevOps environments presents a challenge for continuous testing. Many organizations struggle to get this right. Practices that work for small scale continuous testing may not be sufficient as the requirements grow. In his session at DevOps Summit, Marc Hornbeek, Sr. Solutions Architect of DevOps continuous test solutions at Spirent Communications, will explain the best practices of continuous testing at high scale, which is r...
Mar. 29, 2015 02:00 PM EDT Reads: 1,983
@ThingsExpo has been named the Top 5 Most Influential M2M Brand by Onalytica in the ‘Machine to Machine: Top 100 Influencers and Brands.' Onalytica analyzed the online debate on M2M by looking at over 85,000 tweets to provide the most influential individuals and brands that drive the discussion. According to Onalytica the "analysis showed a very engaged community with a lot of interactive tweets. The M2M discussion seems to be more fragmented and driven by some of the major brands present in the...
Mar. 29, 2015 01:45 PM EDT Reads: 4,657
Countless business models have spawned from the IaaS industry. Resell Web hosting, blogs, public cloud, and on and on. With the overwhelming amount of tools available to us, it's sometimes easy to overlook that many of them are just new skins of resources we've had for a long time. In his General Session at 16th Cloud Expo, Phil Jackson, Lead Developer Advocate at SoftLayer, will break down what we've got to work with and discuss the benefits and pitfalls to discover how we can best use them t...
Mar. 29, 2015 01:15 PM EDT Reads: 1,441